Inaugural Sydney Biomedical Accelerator lecture: Sir Robert Lechler
Event overview
We are immensely pleased to welcome the distinguished Sir Robert Lechler of King’s College, London and Quell Therapeutics to Sydney to deliver the inaugural Sydney Biomedical Accelerator lecture.
Sir Robert is internationally regarded as an academic leader in health and translational science, and celebrated for his contributions to transplant immunology and immune tolerance.
Please join us for the lecture, ‘Accelerating the translation of discovery into patient benefit’ to hear first-hand from Sir Robert about his journey from basic science to a biotech company-led trial. He will discuss the steps that institutions can take to facilitate the translation of research into societal benefit.
Event details
Date: Tuesday 27 October
Time: 12:30 – 1:30 pm, with light refreshments from 1:30 pm
Location: Charles Perkins Centre Auditorium, University of Sydney
Format: In person only
About Sir Lechler
Sir Robert Lechler
Sir Robert Lechler recently stepped down from his roles as Senior Vice-President (Health) at King’s College London and Executive Director of King’s Health Partners Academic Health Sciences Centre and President of the Academy of Medical Science. He is currently Professor of Immunology at King’s College London, Co-chair of SC1, a life sciences cluster in South East London, Non-Executive Director on the Board of Quell Therapeutics Limited, Non-Executive Director on the Board of MiNA Tx, Chairs an External Advisory Board for Birmingham Health Partners, and Chairs the research committee of the Royal College of Surgeons. His clinical and research career have been focused on the pursuit of clinical transplantation tolerance. He worked in in vitro and in vivo rodent models and recently has helped to define biomarkers of clinical tolerance. This work has led to first-in-human trials of cell therapy to promote immune tolerance in recipients of kidney and liver organ transplants. In 2012 Robert was awarded a Knighthood in the Queen’s Birthday Honours for Services to Academic Medicine and in 2015 he was elected as the President of the UK Academy of Medical Sciences, a post he held until 2020. In addition, Robert was a Founding Board Member of MedCity, was a Board Member of the Crick Institute, and is still leading a project for the Prime Minister’s Council for Science and Technology. He is a strong advocate of the Academic Health Science Centre model of university-healthcare partnerships. In recent years he has promoted the development of life sciences clusters, drawing life science industries into closer partnership with healthcare and academia. Doing this in a way that reduces health inequality and promotes population health is a pressing challenge for many countries in the developed world. This imperative has been further highlighted by the recent Covid pandemic.
FAQs
- Is parking avaliable?
There is limited parking on the Camperdown/Darlington Campus. The availability of parking at the University varies and in the interests of sustainability we encourage people to use public transport, walk or cycle in by using bicycle parking, safe pedestrian routes, and the campus bus. Visit our Getting to campus page for more information.
- Who can I contact with questions?
The event is being managed by the Sydney Biomedical Accelerator program team. Please contact us at info@sydneybiomedicalaccelerator.org
Tickets for good, not greed Humanitix dedicates 100% of profits from booking fees to charity
